Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02686489 · ClinicalTrials.gov registry record · NA
Humidity Therapy for Spontaneously Breathing Tracheostomy Patients
A NA study, sponsored by Rush University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02686489: Clinical Trial NA study, sponsored by Rush University Medical Center.
NCT02686489 is a NA study that was terminated before completion, run by Rush University Medical Center. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02686489, a NA study, was terminated before completion, sponsored by Rush University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The goal of the study is to compare the safety and efficacy of molecular water and bland aerosol therapy (particulate water) in providing adequate humidity to the inspired gas of spontaneously breathing tracheostomy patients.
Primary Outcome
Pulmonary infection rate as determined by CPIS score
Interventions
- OTHER Heated humidification
- OTHER Cool bland aerosol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-03-24 |
| Est. Completion | 2018-08-11 |
| Phase | NA |
Why NCT02686489 stopped before completion
NCT02686489 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Heated humidification is the first listed.
NCT02686489 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02686489 about?
NCT02686489 is a clinical study titled "Humidity Therapy for Spontaneously Breathing Tracheostomy Patients". The goal of the study is to compare the safety and efficacy of molecular water and bland aerosol therapy (particulate water) in providing adequate humidity to the inspired gas of spontaneously breathing tracheostomy patients.
What is the current status of trial NCT02686489?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2017-03-24. Estimated completion is 2018-08-11.
What interventions are being tested in trial NCT02686489?
The interventions under investigation include: Heated humidification (OTHER), Cool bland aerosol (OTHER).
Who is sponsoring clinical trial NCT02686489?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02686489's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI